News

Shifts in resting-state brain networks as a result of aging could underlie the natural decline in social engagement.
New research using fruit flies reveals that Alzheimer’s disease impacts not just the brain, but the entire body. Alzheimer’s ...
Dr. Daniel Gibbs had a general knowledge of Alzheimer's disease when he was a practicing neurologist. He knows a lot more now ...
The major hypothesis being pursued is that while either oxidative stress or abnormalities in mitotic signalling can independently serve as initiators, both processes are necessary to propagate disease ...
In this article, we explore a connection between fine-tuned Transformer models and unsupervised LDA approach to cope with text sentiment analysis tasks, inspired by the concept of Neuro-symbolic AI.
The SOFIA 88 neurovascular support catheter offers a 0.088in inner diameter with engineering enhancements. Credit: ©2025 Terumo Neuro. Terumo Neuro (formerly MicroVention) has launched the SOFIA 88 ...
Bucharest mayor and independent presidential candidate Nicușor Dan is ahead of George Simion, the leader of far-right party AUR, in voting intentions, according to a poll presented on Thursday ...
This, as Eric Zhu, one of the founders of Sperm Racing, pointed out to me, is tricky because “the timeline is very, very tight. Let’s just say we have these guys jerking off like 10 or 20 ...
First of five Phase 2 trials for AL001 begins in healthy subjects with topline data expected by end of 2025. Preclinical data showed AL001 improved brain absorption with lower blood lithium levels ...
ClearPoint Neuro (Nasdaq:CLPT) announced today that it entered into a note financing agreement with Oberland Capital Management of up to $110 million. The agreement includes $30 million in gross ...
Hundreds of runners took to the scenic lanes of Prestwood in Buckinghamshire on Sunday for Run Prestwood, a vibrant community event that raised an incredible £9,089 for the Wendover-based Chilterns ...
SOLANA BEACH, CALIFORNIA / ACCESS Newswire / May 12, 2025 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise ...